Particularly, the inhibition effect on AChE (IC50: 16.116 μg/mL) and BChE (IC50: 8.556 μg/mL) suggests the potential therapeutic application of MLs in the treatment of neurodegenerative diseases such as Alzheimer's. Here, BCHE is linked to neurodegenerative disease.